Clinical trialPhase 3Completed
Two Chemotherapy Regimens Compared With Observation in Treating Patients With Completely Resected Pancreatic Cancer
European Study Group For Pancreatic Cancer - Trial 3
- Outcome
- Finished, no results posted
- Phase
- Phase 3
- Status
- Completed
- Study type
- Interventional
- Start
- July 2001
- Expected end
- September 2010
- Enrollment
- 1,030 participants
- Sites
- 27
- Primary outcomes
- Overall survival
- Sponsor
- Other gov
- Results posted
- No
- Last update
- 18 December 2013
These are registry fields. A trial card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try
Papers 4
- Registry-listed results paperEffect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patien… DOI 10.1001/jama.2012.7352↗
- Registry-listed results paperAdjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a rando… DOI 10.1001/jama.2010.1275↗
- Builds on itPatterns of Recurrence After Resection of Pancreatic Ductal Adenocarcinoma: A Secondary Analysis of the ESPAC-4 Randomi… DOI 10.1001/jamasurg.2019.3337↗
- Builds on itThe Impact of Positive Resection Margins on Survival and Recurrence Following Resection and Adjuvant Chemotherapy for P… DOI 10.1097/sla.0000000000002557↗
The registry lists these as results papers; in a hand check of 27 such links about 78% reported the trial’s results, so read the paper before treating it as the outcome.